Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C
- 28 August 2002
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16 (9) , 1623-1632
- https://doi.org/10.1046/j.1365-2036.2002.01326.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Factors influencing ribavirin-induced hemolysisJournal of Hepatology, 2001
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trialsGastroenterology, 1999
- Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trialPublished by Elsevier ,1999
- Treatment with Interferon-Alpha2a Alone or Interferon-Alpha2a plus Ribavirin in Patients with Chronic Hepatitis C Previously Treated with Interferon-Alpha2aScandinavian Journal of Gastroenterology, 1999
- Severe anemia following combined α-interferon/ribavirin therapy of chronic hepatitis CJournal of Hepatology, 1998
- Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trialHepatology, 1998
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortalityJournal of Hepatology, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986